Association of CD38 Antigen Expression with Other Prognostic Parameters in Early Stages of Chronic Lymphocytic Leukemia
- 1 January 2001
- journal article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 42 (6), 1315-1321
- https://doi.org/10.1080/10428190127505
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Genomic Aberrations and Survival in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2000
- Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2000
- Prognostic relevance of a scoring system based on clinical and biological parameters in early chronic lymphocytic leukemiaThe Hematology Journal, 2000
- Clinico‐prognostic implications of simultaneous increased serum levels of soluble CD23 and β2‐microglobulin in B‐cell chronic lymphocytic leukemiaEuropean Journal of Haematology, 1999
- Chlorambucil in Indolent Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 1998
- Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 1995
- Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agentBlood, 1993
- Progression and survival studies in early chronic lymphocytic leukemiaBlood, 1991
- A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysisCancer, 1981
- Clinical staging of chronic lymphocytic leukemiaBlood, 1975